Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,577 public trials 586 recruiting studies

Refine in advanced search Browse all conditions

Stomach Diseases trial results

Active, Not Recruiting

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

NCT02407119

Conditions: Atrophy, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea

View Trial Details

Active, Not Recruiting

Helicobacter Pylori Eradication to Prevent Gastric Cancer

NCT01133951

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +11 more
Locations: Zhao-Lai Hua M.D. Yangzhong, Jiangsu, China

View Trial Details

Active, Not Recruiting

IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy

NCT04611997

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +12 more
Locations: Chang-ming Huang Fuzhou, Fujian, China

View Trial Details

Active, Not Recruiting

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

NCT03347162

Conditions: Cancer, Cancer of Esophagus, Cancer of Liver, +24 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

NCT03488667

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: The University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Active, Not Recruiting

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

NCT02496273

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

NCT02485015

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +5 more
Locations: Not specified

View Trial Details

Stomach Diseases

Stomach Diseases trial results

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

Helicobacter Pylori Eradication to Prevent Gastric Cancer

IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

Related conditions